Nautilus Biotechnology, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Nautilus Biotechnology, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $102.00K, a 1175.00% increase year-over-year.
- Nautilus Biotechnology, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $1.10M, a 6038.89% increase year-over-year.
- Nautilus Biotechnology, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $32.00K, a 84.39% decline year-over-year.
- Nautilus Biotechnology, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Nautilus Biotechnology, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $58.00K, a 90.65% decline from fiscal 2024.
- Nautilus Biotechnology, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $620.00K, a 496.15% increase from fiscal 2023.
- Nautilus Biotechnology, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $104.00K, a 68.48% decline from fiscal 2022.
- Nautilus Biotechnology, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $330.00K, a 97.60% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $102.00K 10-Q · filed 2026-07-28 | $1.24M derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | $1.10M 10-Q · filed 2026-04-28 | $1.15M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $58.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $231.00K derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | $8.00K 10-Q · filed 2026-07-28 | $371.00K derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $18.00K 10-Q · filed 2026-04-28 | $393.00K derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $620.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $140.00K 10-Q · filed 2025-10-28 | $496.00K derived: sum of 4 quarters · filed 2025-10-28 |
| 2024-06-30 | $30.00K 10-Q · filed 2025-07-31 | $372.00K derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $245.00K 10-Q · filed 2025-04-29 | $348.00K derived: sum of 4 quarters · filed 2025-04-29 |
| 2023-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $104.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $16.00K 10-Q · filed 2024-10-29 | $79.00K derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | $6.00K 10-Q · filed 2024-07-30 | $149.00K derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | $1.00K 10-Q · filed 2024-04-30 | $175.00K derived: sum of 4 quarters · filed 2024-04-30 |
| 2022-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $330.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $86.00K 10-Q · filed 2023-10-31 | $337.00K derived: sum of 4 quarters · filed 2023-10-31 |
| 2022-06-30 | $32.00K 10-Q · filed 2023-08-02 | $309.00K derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $156.00K 10-Q · filed 2023-05-02 | $323.00K derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $167.00K 10-K · filed 2023-02-23 |
| 2021-09-30 | $58.00K 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $46.00K 10-Q · filed 2022-08-02 | |
| 2020-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $42.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $28.00K 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $4.00K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |